Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | RGS12 | O14924 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.44 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1561003 | 0.87 | CYP1A2 (0.55) | CYP1A2CYP2C19AKR1B1NR1H4HPGD | |
| SCHEMBL3623604 | 0.86 | CYP1A2 (0.62) | CYP1A2CYP2C19AKR1B1NR1H4HPGD | |
| SCHEMBL70565 | 0.84 | AKR1B1 (0.71) | CYP1A2CYP2C19AKR1B1HPGDHSD17B10 | |
| SCHEMBL13898748 | 0.84 | CYP1A2 (0.44) | CYP1A2CYP2C19KDM4ELMNAPOLB | |
| SCHEMBL14090658 | 0.83 | LMNA (0.58) | CYP1A2CYP2C19AKR1B1NR1H4HPGD | |
| Hydrochloric Acid SCHEMBL8922940 | 0.82 | AKR1B1 (0.68) | CYP1A2CYP2C19AKR1B1HPGDHSD17B10 | |
| SCHEMBL9321449 | 0.81 | AKR1B1 (0.52) | CYP1A2CYP2C19AKR1B1NR1H4HPGD | |
| SCHEMBL18116097 | 0.81 | CYP1A2 (0.57) | CYP1A2CYP2C19AKR1B1NR1H4HPGD | |
| SCHEMBL9244144 | 0.80 | ESR1 (0.56) | AKR1B1NR1H4HPGDHSD17B10GAA | |
| SCHEMBL15042342 | 0.79 | AKR1B1 (0.54) | CYP1A2CYP2C19AKR1B1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9884067-B2 | Androgen receptor down-regulating agents and uses thereof | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2018-02-06 | — | — | US | disclosed |
| US-9439912-B2 | Androgen receptor down-regulating agents and uses thereof | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2016-09-13 | — | — | US | disclosed |
| US-20160000808-A1 | ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-07 | — | — | US | disclosed |
| US-20150361126-A1 | ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF | UNIVERSITY OF MARYLAND, BALTIMORE | 2015-12-17 | — | — | US | disclosed |
| WO-2014089048-A1 | TREATMENT OF CANCER WITH HETEROCYCLIC INHIBITORS OF GLUTAMINASE | CALITHERA BIOSCIENCES, INC. (US) | 2014-06-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160000808-A1 | ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF | AR, NR5A1, ESRRA | CYP1A2 1994/4885CYP2C19 3671/4885AKR1B1 86/4885 |
| US-20150361126-A1 | ANDROGEN RECEPTOR DOWN-REGULATING AGENTS AND USES THEREOF | AR, NR5A1, ESRRA | CYP1A2 1994/4885CYP2C19 3671/4885AKR1B1 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.